Trial Details

A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous Phase 2 And 3 EDP1815 Trials

NCT05439941

TERMINATED

DESCRIPTION

This is an Open-Label Extension (OLE) study to evaluate the long-term safety, tolerability, and efficacy of EDP1815 in participants with mild, moderate, and severe atopic dermatitis who have completed the treatment period of a prior clinical study ("parent study") with EDP1815. The current parent study of this protocol is the EDP1815-207 study; A Phase 2, Multicenter, Double-Blind, Placebo-Controlled, Multiple-Cohort Study Investigating the Effect of EDP1815 in Participants for the Treatment of Mild, Moderate and Severe Atopic Dermatitis.

CONDITIONS

ELIGIBILITY CRITERIA

• Inclusion Criteria
• : 1. Must have provided informed consent. 2. Must have completed the treatment period in a parent study of EDP1815 in atopic dermatitis and complied with the parent protocol. 3. Must agree to use emollients. 4. Must continue to follow contraception criteria.